KR20210149144A - 두경부 표피암의 검출용 타액 바이오마커 - Google Patents

두경부 표피암의 검출용 타액 바이오마커 Download PDF

Info

Publication number
KR20210149144A
KR20210149144A KR1020217036142A KR20217036142A KR20210149144A KR 20210149144 A KR20210149144 A KR 20210149144A KR 1020217036142 A KR1020217036142 A KR 1020217036142A KR 20217036142 A KR20217036142 A KR 20217036142A KR 20210149144 A KR20210149144 A KR 20210149144A
Authority
KR
South Korea
Prior art keywords
saliva
cancer
genus
subject
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020217036142A
Other languages
English (en)
Korean (ko)
Inventor
로페즈 비센테 마누엘 나바로
Original Assignee
바이오뉴 리서치 에스.엘.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이오뉴 리서치 에스.엘. filed Critical 바이오뉴 리서치 에스.엘.
Publication of KR20210149144A publication Critical patent/KR20210149144A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56955—Bacteria involved in periodontal diseases
    • G01N33/57407—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
KR1020217036142A 2019-04-05 2020-04-06 두경부 표피암의 검출용 타액 바이오마커 Pending KR20210149144A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19382253.3A EP3719498A1 (en) 2019-04-05 2019-04-05 Salivary biomarkers for the detection of head and neck epidermoid cancer (cecc)
EP19382253.3 2019-04-05
PCT/EP2020/059761 WO2020201575A1 (en) 2019-04-05 2020-04-06 Salivary biomarkers for the detection of epidermoid cancer of the head and neck

Publications (1)

Publication Number Publication Date
KR20210149144A true KR20210149144A (ko) 2021-12-08

Family

ID=67437232

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217036142A Pending KR20210149144A (ko) 2019-04-05 2020-04-06 두경부 표피암의 검출용 타액 바이오마커

Country Status (10)

Country Link
US (1) US12584178B2 (https=)
EP (2) EP3719498A1 (https=)
JP (1) JP7557789B2 (https=)
KR (1) KR20210149144A (https=)
CN (1) CN114008458A (https=)
AU (1) AU2020252417B2 (https=)
CA (1) CA3135976A1 (https=)
ES (1) ES3053185T3 (https=)
PL (1) PL3948285T3 (https=)
WO (1) WO2020201575A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12334375B2 (en) 2019-08-08 2025-06-17 Lam Research Corporation Spindle assembly for wafer transfer in a multi-station process module
KR20240052707A (ko) * 2022-10-14 2024-04-23 국립암센터 구강 미생물총 기반 구강암의 진단

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10954571B2 (en) * 2016-06-23 2021-03-23 The Charlotte-Mecklenburg Hospital Authority Compositions and methods for oral microbiome signatures
KR101854523B1 (ko) * 2016-06-30 2018-05-04 연세대학교 산학협력단 폐암의 진단 또는 폐암의 병기에 관한 정보를 제공하는 방법 및 이를 이용하는 키트

Also Published As

Publication number Publication date
EP3948285C0 (en) 2025-09-03
US20220170111A1 (en) 2022-06-02
US12584178B2 (en) 2026-03-24
ES3053185T3 (en) 2026-01-20
AU2020252417B2 (en) 2025-12-18
EP3719498A1 (en) 2020-10-07
EP3948285B1 (en) 2025-09-03
CN114008458A (zh) 2022-02-01
EP3948285A1 (en) 2022-02-09
WO2020201575A1 (en) 2020-10-08
JP7557789B2 (ja) 2024-09-30
AU2020252417A1 (en) 2021-12-02
PL3948285T3 (pl) 2025-12-01
CA3135976A1 (en) 2020-10-08
JP2022529909A (ja) 2022-06-27

Similar Documents

Publication Publication Date Title
KR102930361B1 (ko) 암의 평가 및/또는 치료를 위한 무 세포 dna
US12275996B2 (en) Head and neck squamous cell carcinoma assays
CN114736968A (zh) 血浆游离dna甲基化标志物在肺癌早筛中的用途以及肺癌早筛装置
CN103459597A (zh) 用于预测胃癌预后的标记和用于预测胃癌预后的方法
CN113724862B (zh) 一种结直肠癌生物标志物及其筛选方法和应用
Heawchaiyaphum et al. Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches
JP6766312B2 (ja) 子宮頸癌のバイオマーカー
KR20230025895A (ko) 순환 종양 핵산 분자의 다중모드 분석
CN102424840A (zh) 尿液诊断膀胱癌患者复发危险性的方法和试剂盒
KR20210149144A (ko) 두경부 표피암의 검출용 타액 바이오마커
Lin et al. Analysis of the triage value of multigene methylation testing for CIN2+ in hrHPV-positive patients
CN118932064B (zh) 一种用于检测非小细胞肺癌mrd的探针组及其应用
AU2004250246A1 (en) Methods for disease screening
US20130288918A1 (en) Colorectal Cancer Screening Method
CN118006815A (zh) 具核梭杆菌特异性dna序列及其应用和检测方法
CN114480636A (zh) 胆汁细菌作为肝门部胆管癌诊断及预后标志物的用途
CN114854855A (zh) 食管癌的生物标志物、核酸产品和试剂盒
KR102954588B1 (ko) 기관지폐포세척액의 마이크로바이옴을 포함하는 폐암 진단용 바이오마커 조성물
CN113564250A (zh) 头颈部癌症的生物标志物及其使用方法
WO2019095541A1 (zh) 一种诊断预示乳腺癌骨转移的组合物及诊断预示方法
JP7558511B2 (ja) 被験者の脳微小出血の重症化リスクを予測するための方法、脳微小出血の重症化リスクの高い被験者をスクリーニングするための方法、及びそれらに用いるキット
KR20240176856A (ko) 기관지폐포세척액의 마이크로바이옴을 포함하는 폐암 진단용 바이오마커 조성물
Zhou et al. Houcong Liu1, 4, Loren Hansen2, 4, Changpu Song3, Haijiu Lin3, Dan Chen3, Zhufang Chen1
CN117701576A (zh) 基于甲基化修饰的泛癌标记物khdrbs2基因
CN119433015A (zh) 一种用于突发性聋治疗敏感性预测的5hmC分子标记物及其应用

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000